Bicara Therapeutics Inc (NAS:BCAX)
$ 29.34 +2.47 (+9.19%) Market Cap: 1.93 Bil Enterprise Value: 1.39 Bil PE Ratio: 0 PB Ratio: 3.74 GF Score: 12/100

Bicara Therapeutics Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2026 / 07:15 PM GMT


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BCAX.OQ - Bicara Therapeutics Inc
Bicara Therapeutics Inc at JPMorgan Healthcare Conference
Jan 12, 2026 / 07:15PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, everyone, and welcome to day one of the forty-fourth annual JPMorgan Healthcare Conference here in San Francisco. My name is Alex Kramer and I'm a member of the JPMorgan Healthcare Investment Banking team. It's my pleasure to introduce our next presenting company, Bkarra Therapeutics. I'm joined by CEO Claire Mazumdar, who will be giving the presentation today. Following Claire's remarks, there will be a time at the end for Q&A, so I ask that you hold your questions until the end.

For that portion of the presentation, I will also ask President and CEO Ryan Cohab to come up as well.

With that said, Claire, please take it away.

----------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot